Related Experiment Video

Updated: Nov 5, 2025

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.9K

The effect of autocrine motility factor alone and in combination with methyl jasmonate on liver cancer cell growth

Nam Ho Jeoung1, Ae Lim Jo1, Hee Sung Park2

  • 1Department of Pharmaceutical Engineering, Catholic University of Daegu, Gyeongsan, Korea.

Bioscience, Biotechnology, and Biochemistry
|May 14, 2021
PubMed

Insights

Autocrine motility factor (AMF) from colorectal cancer cells suppressed liver cancer by reducing pAKT and β-catenin. AMF enhanced methyl jasmonate therapy, offering a new approach for liver cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Cell Biology

Background:

  • Neoplastic cells release autocrine motility factor (AMF) to promote cancer cell motility.
  • Understanding AMF's role in inter-organ cancer metastasis is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the effect of AMF secreted by HT-29 colorectal cancer cells on liver cancer cells.
  • To explore the therapeutic potential of AMF in combination with methyl jasmonate for liver cancer.

Main Methods:

  • Culturing HT-29 colorectal cancer cells and liver cancer cells.
  • Analyzing the impact of HT-29 secreted AMF on liver cancer cell signaling pathways (pAKT, β-catenin).
  • Evaluating the synergistic effect of AMF and methyl jasmonate on liver cancer cell viability and activity.

Main Results:

  • AMF secreted by HT-29 cells selectively suppressed liver cancer cell growth.
  • Downregulation of pAKT and β-catenin signaling pathways was observed in liver cancer cells treated with AMF.
  • HT-29 AMF significantly enhanced the anti-cancer activity of methyl jasmonate against liver cancer cells.

Conclusions:

  • AMF from colorectal cancer plays a suppressive role in liver cancer progression.
  • Targeting AMF-mediated signaling pathways presents a potential therapeutic strategy for liver cancer.
  • The combination of AMF and methyl jasmonate shows promise as an alternative liver cancer therapy.
Keywords:
HT29 colon cancer cellsautocrine motility factorliver cancer cellsmethyl jasmonate

More Related Videos

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

540
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

550

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K